The Manitowoc Company Announces Upcoming Change in its Board of Directors
The Manitowoc Company Announces Upcoming Change in its Board of Directors
The Manitowoc Company, Inc. (NYSE: MTW) announced today that board member John C. Pfeifer has chosen not to stand for reelection to the Company’s Board of Directors; therefore, his term will end at the May 7, 2024 annual meeting of shareholders. First appointed to the Manitowoc board in 2016, as the President and Chief Executive Officer of Oshkosh Corporation Mr. Pfeifer brought expert and deep operational experience and advice from the machinery industry. He was instrumental in shaping Manitowoc’s strategy for growth in envisioning Manitowoc’s strategy shift from a solely product-focused company to being more service-oriented.
“John brought sage and invaluable advice that was instrumental in steering the successful Manitowoc that it is today. Over the last seven years, he contributed his expertise in operations, finance, acquisition strategies, and a deep understanding of the construction equipment business, for which we are grateful,” commented Kenneth W. Krueger, Chairman of The Manitowoc Company, Inc.
About The Manitowoc Company, Inc.
The Manitowoc Company was founded in 1902 and has over a 120-year tradition of providing high-quality, customer-focused products and support services to its markets. Headquartered in Milwaukee, Wisconsin, United States, Manitowoc is one of the world's leading providers of engineered lifting solutions. Manitowoc, through its wholly-owned subsidiaries, designs, manufactures, markets, distributes and supports comprehensive product lines of mobile hydraulic cranes, lattice-boom crawler cranes, boom trucks, and tower cranes under the Aspen Equipment, Grove, Manitowoc, MGX Equipment Services, National Crane, Potain, and Shuttlelift brand names.
Ion Warner
Senior Vice President
Marketing and Investor Relations
+1 414-760-4805
View source version on businesswire.com: https://www.businesswire.com/news/home/20240322708036/en/
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing